UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 12, 2014
OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in charter)
|
Maryland
|
1-11316
|
38-3041398
|
|
(State of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
200 International Circle
Suite 3500
Hunt Valley, Maryland 21030
(Address of principal executive offices / Zip Code)
(410) 427-1700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act.
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 12, 2014, Omega Healthcare Investors, Inc. (the “Company”) held its Annual Meeting of Stockholders.
At the Annual Meeting, there were present in person or by proxy 115,107,224 shares of Omega’s common stock, representing approximately 92% of the total outstanding eligible votes. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:
Proposal 1: Election of Directors
|
Votes Cast in Favor
|
Votes Withheld
|
Broker Non-Votes
|
|
|
Barbara B. Hill
|
83,643,439
|
547,206
|
30,916,579
|
|
Harold J. Kloosterman
|
80,645,749
|
3,544,896
|
30,916,579
|
|
C. Taylor Pickett
|
83,594,106
|
596,539
|
30,916,579
|
Proposal 2: Ratification of the selection of Ernst & Young LLP as Omega’s independent auditor for 2014
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|
114,400,039
|
313,048
|
394,137
|
-
|
Proposal 3: Advisory vote on the Company’s executive compensation
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|
81,343,477
|
2,300,221
|
546,947
|
30,916,579
|
Each of the director nominees was elected, the selection of Ernst & Young LLP was ratified and the Company’s executive compensation was approved on an advisory basis.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OMEGA HEALTHCARE INVESTORS, INC.
(Registrant)
Dated: June 16, 2014 By: /s/ Robert O. Stephenson
Robert O. Stephenson
Chief Financial Officer